| 摘要 |
The invention concerns pharmaceutical compositions containing in combination a of arginine-vasopressin V1a antagonist and an angiotensin II AT1 receptor antagonist. The use of said combination is useful for treating cardiac deficiency, high blood pressure and nephropathy. |
